Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.
Pranax has raised $17.0M in total funding. The most recent round was Series A. The last funding was announced in January 2026.
Pranax is headquartered in Houston, United States.
Pranax is a biotechnology company that develops and commercializes regenerative medicine solutions centered on exosome technology.
Pranax is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Pranax — Funding & Investors." VCBacked, January 29, 2026, https://www.vcbacked.co/company/pranax. Accessed September 15, 2026.
VCBacked. (2026). Pranax — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/pranax
{{cite web |title=Pranax — Funding & Investors |url=https://www.vcbacked.co/company/pranax |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated